Delivery Order SPE2DB24D2205-SPE2DB25FDUAM
Award Date
11/13/24
Potential Completion Date
11/14/24
Potential Value
$11K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Rifampin 300 mg capsules. The contract is a firm fixed-price delivery order with a ceiling value of $3,992.80 and an ultimate completion date of February 13, 2025. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as...
This is a delivery order federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Medical Supply Chain. The contract is for the delivery of Rifampin 300mg capsules, a pharmaceutical product, with a ceiling value of $106,743.73 and a performance period through June 18, 2025. The contract is a Firm Fixed Price, non-set-aside award. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Rifampin 300 mg capsules. The $8,227.77 firm fixed-price contract has an ultimate completion date of August 8, 2024. Amerisourcebergen is delivering these pharmaceutical products under a larger indefinite delivery contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for providing a comprehensive...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,568,160,692 units of Rifampin 300 mg capsules. The contract has a ceiling value of $5,109.58 and a period of performance through May 7, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to supply Rifampin 300 mg capsules. The contract is valued at $3,894.85 and has a completion date of September 25, 2023. The contract is a Firm Fixed Price Delivery Order, and there is no set-aside designation indicated. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of Rifampin 300 mg capsules. The order is valued at $6,351.40 and has a period of performance through August 30, 2024. This delivery order is placed against an Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with DLA Troop Support Medical, which has a potential value of up to $999,999,999 and provides a broad range of pharmaceutical and medical supplies to military...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide Rifampin 300 mg capsules. The contract is a firm fixed price arrangement with a ceiling value of $26,204.77 and a period of performance through March 13, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of Rifampin capsules. The contract has a firm fixed price and a ceiling value of $86,447.52, with a period of performance ending on July 2, 2025. The contract is not set aside and was awarded on July 1, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the...
This is a delivery order federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the supply of Rifampin 300 mg capsules, a critical antibiotic medication, to support military treatment facilities and other federal healthcare providers. The contract has a ceiling value of $18,609.46 and an ultimate completion date of August 29, 2024. It is a firm-fixed-price contract, with no set-aside designation....
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of 60 count bottles of 300 mg Rifampin capsules. The contract has a ceiling value of $21,942.69 and an ultimate completion date of March 26, 2025. The award was made on March 25, 2025, and there was no set-aside designation used. AmerisourceBergen, a major pharmaceutical distributor, holds a significant Indefinite Delivery Contract (IDC) valued at $999,999,999...